Key result
Each HF hospitalization linked to rising 10-year mortality, reaching ~41% after three or more admissions.
Why the study?
The natural trajectory of HF remains poorly understood in real-world settings, and limited studies have quantified how recurrent hospitalizations impact future hospitalization and mortality risk.
Cohort (n=12,157)
In a real-world cohort, heart failure exhibits an event-driven progression where each subsequent hospitalization significantly increases the risk of future hospitalizations and long-term mortality across all ejection fraction subtypes.
Answers are grounded in this paper and cite their sources.
Recurrent HF hospitalizations associate with rising mortality across EF subtypes; leaves open whether targeted interventions can alter trajectories.
Background Heart failure (HF) is a progressive condition characterized by recurrent hospitalizations and high mortality. While early intervention with guideline-directed medical therapy (GDMT) can improve outcomes, the natural trajectory of HF remains poorly understood in real-world settings. Each hospitalization event may increase the probability of future hospitalizations and mortality, yet limited studies have quantified this risk. This study aimed to assess the progression of HF and the cumulative impact of recurrent hospitalizations on mortality using a multi-state model approach in a large real-world cohort. Methods This retrospective cohort study included 12,157 HF patients from 2010 to 2024, stratified by HF subtype: HF with reduced ejection fraction (HFrEF, 17.1%), HF with mildly reduced ejection fraction (HFmrEF, 11.9%), and HF with preserved ejection fraction (HFpEF, 71.0%). A multi-state model was used to estimate transition probabilities between clinical states: initial HF diagnosis, first hospitalization (HFH1), second hospitalization (HFH2), recurrent hospitalization (HFH3+), and all-cause death. Transition probabilities were analyzed at 1, 5, and 10 years, and subgroup analyses were performed for HF subtypes. Results Over 10 years, 61.5% of patients remained in their initial HF state, while 19.0% progressed to HFH1, 5.5% to HFH2, and 2.5% to HFH3+. Mortality risk increased with each hospitalization, reaching 41.0% in HFH3+ patients compared to 19.0% in non-hospitalized HF patients. The risk of death increased over time, with 1-year, 5-year, and 10-year mortality rates of 3.7%, 9.8%, and 19.0%, respectively. Each subsequent hospitalization further increased the probability of future hospitalizations and mortality. Among HFH1 patients, 33.0% progressed to HFH2, and 39.8% of HFH2 patients advanced to HFH3+. At 10 years, HFH1 patients had a 33.0% mortality rate, which increased to 38.4% after HFH2 and 41.0% after HFH3+. These findings were consistent across HF subtypes, with HFrEF patients exhibiting the fastest disease progression, while HFpEF patients, despite slower initial progression, demonstrated high long-term mortality. Conclusion Heart failure exhibits a time-dependent and event-driven progression, where each hospitalization increases the likelihood of future hospitalizations and death. The probability of mortality rises significantly with recurrent hospitalizations, emphasizing the need for early intervention and hospitalization prevention strategies. Multi-state modeling offers a valuable framework for evaluating disease trajectories, supporting the need for proactive treatment and optimized GDMT to mitigate the burden of hospitalizations and improve long-term outcomes in HF patients.
No takes yet. Share an insight, caveat, or question.
Amornritvanich et al. (2025) conducted a cohort in Heart failure (n=12,157). Recurrent hospitalizations vs. Non-hospitalized HF patients was evaluated on All-cause death. Recurrent hospitalizations in heart failure patients progressively increased 10-year mortality risk, reaching 41.0% in those with ≥3 hospitalizations compared to 19.0% in non-hospitalized patients.
Synapse has enriched 10 related papers. Consider them for comparative context: